66
Participants
Start Date
December 27, 2023
Primary Completion Date
April 30, 2026
Study Completion Date
April 30, 2026
Sutetinib Maleate Capsule
Oral administration
RECRUITING
Perlmutter Cancer Center - 34th Street, New York
ACTIVE_NOT_RECRUITING
Northwell Health, New Hyde Park
RECRUITING
University Cancer & Blood Center (UCBC) - Athens, Athens
RECRUITING
Moffitt Cancer Center, Tampa
WITHDRAWN
Norton Cancer Institute - Downtown, Louisville
RECRUITING
Mission Cancer + Blood - Mission Cancer Foundation, Des Moines
RECRUITING
University of Texas MD Anderson Cancer Center, Houston
WITHDRAWN
Oncology Physicians Network Healthcare, Glendale
RECRUITING
University of California San Diego Moores Cancer Center, La Jolla
Teligene US
INDUSTRY